Össur hf
Össur hf
1,95 %
41,85 DKK
0,80
Kurs
41,85
Hög
43,25
Förändring
1,95 %
Låg
41,30
Uppdaterad
2019-07-16
Öppen
42,50
Factsheet for Össur hf
Company Profile
Description
Ossur hf design, development, manufacture, and sale of non-invasive orthopedic products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are Bracing and Support, and Prosthetics segment. The bracing and supports products are used to support joints and other body parts for therapeutic and preventative purposes. It offers custom-made and off-the-shelf products with a focus on osteoarthritis and injury solutions. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are Europe Middle-East and Africa (EMEA), Americas and Asia-Pacific (APAC) of which EMEA generates a majority of revenue.
Key Stats
Website: http://www.ossur.com
Headquarter country: Iceland
Employees: 2 097
Market Cap (at close 15-07-2019): DKK 17B
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 29,60 37,80 31,70 29,70 22,40
Forward Price/Earnings 23,30
Price/Free Cash Flow 42,60 39,80 36,30 36,00 18,60
Return on Assets 9,30 7,50 7,30 7,70 8,60
Return on Equity 15,40 11,90 11,00 11,40 13,40
Return on Invested Capital 11,60 9,40 9,00 9,60 10,70
Dividend


Dividend/Share:0,00
Ex. Dividend Date:2018-12-31
Trailing Dividend Yield:0,33
Payout Ratio:10,73
Date Currency Amount
2019-03-31 USD 0,02
2018-03-31 USD 0,02
2017-03-31 USD 0,02
2016-03-31 USD 0,02
2015-03-31 USD 0,02
2014-03-31 USD 0,02
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 612,88 568,62 520,75 483,03 509,36
Gross Profit 0,39 0,35 0,33 0,30 0,32
Gross Margin % 63,11% 62,39% 63,07% 62,75% 63,44%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 129,00 94,00 93,00 91,00 100,00
Net income 80,00 58,00 51,00 51,00 59,00
Basic Earnings Per Share 0,19 0,13 0,12 0,12 0,13
Operating Income 0,08 0,07 0,07 0,08 0,09
Operating Margin % 12,88% 13,16% 13,86% 16,01% 16,87%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow 69,00 74,00 66,00 66,00 85,00
Capital Expenditures -31,00 -19,00 -25,00 -24,00 -17,00
Free Cash Flow 39,00 55,00 42,00 42,00 68,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 274,01 232,20 210,73 177,42 177,70 193,77
Long Term Assets 639,55 560,84 535,67 476,00 500,08 512,48
Total Assets 913,56 793,04 746,40 653,42 677,78 706,25
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 117,56 126,84 113,97 80,38 85,22 101,52
Long Term Liabilities 166,27 166,00 111,10
Total Liabilities 293,11 279,97 191,48
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings 487,09 419,33 369,69 329,61 293,06 244,20
Treasury Stock
Total Stockholder Equity 534,46 499,92 466,43 461,94 440,83 446,65
Net Tangible Assets -15,49 40,25 26,71 57,59 11,69 2,18